LIPOPROTEIN DISORDER
Clinical trials for LIPOPROTEIN DISORDER explained in plain language.
Never miss a new study
Get alerted when new LIPOPROTEIN DISORDER trials appear
Sign up with your email to follow new studies for LIPOPROTEIN DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to tackle stubborn heart risk factor
Disease control Recruiting nowThis study tests a new medicine called DII235 in 200 adults with high levels of lipoprotein(a), a genetic risk factor for heart disease. Participants will receive either the drug or a placebo to see if DII235 safely lowers these levels over 6 to 12 months. The goal is to find the…
Matched conditions: LIPOPROTEIN DISORDER
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
New shot targets hidden heart risk in 204-Patient trial
Disease control Recruiting nowThis study tests an experimental drug called Kylo-11 in 204 adults with heart disease and high levels of lipoprotein(a), a genetic risk factor that current medicines don't lower well. Participants receive either Kylo-11 or a placebo as a shot, and researchers measure how much Lp(…
Matched conditions: LIPOPROTEIN DISORDER
Phase: PHASE2 • Sponsor: Kylonova (Xiamen) Biopharma co., LTD. • Aim: Disease control
Last updated May 26, 2026 03:51 UTC
-
New study investigates link between blood fat and heart function
Knowledge-focused Recruiting nowThis study looks at how a specific blood fat called lipoprotein(a) affects the stiffness of arteries, the health of blood vessel linings, and the heart's ability to pump. Researchers will follow 300 adults for one year, measuring these factors and tracking any heart problems. The…
Matched conditions: LIPOPROTEIN DISORDER
Sponsor: University of Athens • Aim: Knowledge-focused
Last updated May 26, 2026 03:58 UTC